Influence of performance status on the effectiveness of pembrolizumab monotherapy in first-line for advanced non-small-cell lung cancer: Results in a real-world population

  1. Galán, R.J.
  2. Prado-Mel, E.
  3. Pérez-Moreno, M.A.
  4. Caballano-Infantes, E.
  5. Moreno, S.F.
Revista:
Biology

ISSN: 2079-7737

Any de publicació: 2021

Volum: 10

Número: 9

Tipus: Article

DOI: 10.3390/BIOLOGY10090890 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus